Skip to main content

Table 1 Summary of articles reporting on participant experience measures

From: Trials need participants but not their feedback? A scoping review of published papers on the measurement of participant experience of taking part in clinical trials

Study

Geographical location(s)

Number of trials or facilities in the study

Delivery and administration

Items

Participants surveyed (response rate)

Domains

Almeida et al. (2007) [22]

Portugal

1 facility

Self-report

In person

Before discharge from the study

14

136 (100%)

i) Motivations for taking part

ii) Perception of informed consent

iii) Perception of study participation

Aman et al. (1995) [23]

Not reported

2 trials

Self-report

Postal

4 weeks after enrolment

6

63 (63.5%)

i) Staff characteristics

ii) Study operations

iii) Specific features of trial

iv) Incentives and reinforcements

Bahati et al. (2010) [24]

East Africa

3 facilities

Interviewer

Not reported

Study end

Not reported

Not reported (98%)

i) Satisfaction with service received

ii) Satisfaction with major components of the research study

Bertoli et al. (2007) [25]

Argentina

3 trials

Self-report

Postal

Not reported

34

114 (94.6%)

i) Socio-demographics

ii) Overall trial satisfaction

iii) Quality of information given by the Investigator

iv) Participants’ self-perception of knowledge about randomised controlled trials (RCTs)

v) Objective evaluation of participants’ knowledge about RCTs

Bevan et al. (1993) [26]

UK

1 trial

Interviewer

In person

Not reported

Not reported

199 (99%)

i) Reasons for participation or declining participation

ii) Aspects of trials disliked

Cain et al. (2005) [27]

UK and Republic of Ireland

 

Self-report

Postal

Study end

23

44 (82%)

i) Information provided

ii) Reasons for taking part

iii) Best and worst aspects of participation

iv) Willingness to participate in the future

Dias et al. (2005) [28]

Not reported

1 trial

Self-report

Postal

3.5 year follow-up

19

469 (88%)

i) Staff characteristics

ii) Study operations

iii) Specific features of trial

iv) Incentives and reinforcements

Fearn et al. (2010) [29]

UK

1 trial

Self-report

Postal

Study end

Not reported

910 (59%)

i) Motivations for taking part

ii) Health professional involvement

iii) Randomisation

iv) Filling in questionnaires

v) Experience of participation

Friesen et al. (2016) [30]

USA

1 trial

Self-report

In person

At final clinic appointment

47

180 (98%)

i) Attitudes towards trials

ii) Working with study team

iii) Perception of risk benefit

iv) General satisfaction

Van Gelderen, et al. (1993) [31]

The Netherlands

10 trials

Self-report

Combination of postal, taken home and at end of trial

Study end

12

153 (94%)

i) Reason for participation

ii) Information received

iii) Most unpleasant aspects

iv) Most pleasant aspects

v) Experience of participation

Hassar et al. (1976) [32]

USA

1 trial

Interviewer

Not reported

Study end

12

1503 (80%)

i) Reasons for investigators taking part

ii) Participant impression of clinical studies

iii) Medical practice in general

Henzlova et al. (1994) [33]

USA and Canada

1 trial

Self-report

Not reported

Before close out visit

10

4751 (74%)

i) Primary motivation for participation

ii) Satisfaction with participation and perceived outcome

iii) Effect on health-conscious behaviour

iv) Negative experiences

Kost et al. (2013) [34, 35]

USA

29 facilities

Self-report

Not reported

Study end

76

18,890 (29% of participants surveyed)

i) Informed consent

ii) Trust

iii) Coordination of care

iv) Information, education and communication

v) Respect for participant preferences

Luzurier et al. (2015) [36]

France

1 trial

Self-report

Not reported

Not reported

Not reported

210 (% not reported)

i) Satisfaction (with overall welcome and protocol management)

ii) Motivation for taking part

iii) Participation outlook

Martin et al. (2011) [37]

USA

3 trials

Self-report

Postal

Not reported

47

75 (89%)

i) Understanding of participation

ii) Reasons for participating

iii) General experience

iv) Overall satisfaction

v) Willingness to participate in a future study including a placebo-controlled trial

McAdam et al. (2002) [38]

Not reported

1 trial

Not reported

Not reported

Not reported

7

21 (81%)

i) Information provided

ii) Staff

iii) Research processes

iv) Research outcomes

v) Willingness to participate in the future

Mattson et al. (1985) [39]

USA

1 trial

Self-report/Interview

Postal

Before final follow-up

5

1503 (80%)

i) Perceived benefits

ii) Perceived beneficiaries

iii) Perceived disadvantages

iv) Perceived effects of medication

v) Participation in a future trial

Renfroe et al. (2002) [40]

USA and Canada

1 trial

Self-report

Postal

Study end

7

664 (71%)

i) Would participate again

ii) Main reasons for participation

iii) Study benefits

iv) Study problems

v) Quality of care.

Schron et al. (1997) [41]

USA

1 trial

Self-report

Postal

Final follow-up (4.5 years after enrolment)

10

4281 (82%)

i) Reason for participating

ii) Satisfaction with participating

Tangrea et al. (1992) [42]

USA

1 trial

Self-report

Postal

Study end

7

891 (97%)

i) Benefits

ii) Most unpleasant aspects

iii) Importance

iv) Satisfaction

v) Physical well-being

vi) Willingness to take active treatment if shown to be effective

vii) Participation in future trials

Verheggen et al. (1998) [43]

The Netherlands

26 trials

Personal interview (at start of the trial)

Telephone interview (3 months later)

Not reported

Personal interview = 172 (93%); Telephone interview = 172 (78.5%); control group (only participating in telephone interview) = 34 (100%)

i) Medical technical aspects

ii) Interpersonal

iii) Organisational aspects